Marshall Wace North America’s Novo Nordisk NVO Stock Holding History

Marshall Wace North America’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$290K	Buy	+6,028	New	+$291K	﹤0.01%	1255
2020 Q2	–	Sell	-17,798	Closed	-$536K	–	1374
2020 Q1	$536K	Buy	+17,798	New	+$530K	﹤0.01%	745
2019 Q1	–	Sell	-44,846	Closed	-$1.03M	–	1796
2018 Q4	$1.03M	Buy	+44,846	New	+$997K	0.01%	606
2018 Q3	–	Sell	-71,194	Closed	-$1.64M	–	1231
2018 Q2	$1.64M	Sell	71,194 -318,782	-82%	-$7.58M	0.01%	818
2018 Q1	$9.6M	Buy	+389,976	New	+$10.2M	0.05%	406
2017 Q2	–	Sell	-1,023,836	Closed	-$17.4M	–	1408
2017 Q1	$17.4M	Buy	+1,023,836	New	+$17.8M	0.14%	190

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace North America's NVO Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Novo Nordisk (NVO) in Q3 2021: 6,028 shares worth $290K. The stake represents ﹤0.01% of the portfolio and ranks #1255 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in NVO as recently as Q1 2020.

Marshall Wace North America first reported a position in NVO in Q1 2017 and has held it in 6 quarters since. The position peaked at $17.4M in Q1 2017. 805 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

Marshall Wace North America held 6,028 shares of Novo Nordisk worth $290K as of Q3 2021.
Novo Nordisk was a new Marshall Wace North America position in Q3 2021.
Novo Nordisk made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1255 holding.
Marshall Wace North America first reported a position in Novo Nordisk in Q1 2017 and has held it in 6 quarters since.
Marshall Wace North America's Novo Nordisk position peaked at $17.4M in Q1 2017.
805 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.